Document:

Exhibit 10.5

 

Stock Purchase Agreement, among Interplai, Inc.
and the Registrant, dated as of August 30, 2021

 

STOCK PURCHASE
AGREEMENT

 

This Stock Purchase Agreement
(this “Agreement”) is among Interplai, Inc., a Delaware corporation (the “Company”); the purchaser that is a signatory
hereto (the “Investor”); the holders of the Company’s SAFE contracts that are signatories hereto and listed on Schedule
1 (the “SAFE Holders”); and the additional shareholders of the Company who are signatories hereto and listed on Schedule 2
(the “Shareholders”).

 

The parties agree as follows:

 

A. Sale of the Series A Preferred Stock.

 

1. Purchase and Sale. The
Company has agreed to sell and the Investor has agreed to buy shares of the Company’s Series A Preferred Stock (the “Series
A Preferred”) in the amount and at the price per share shown on the signature page of this Agreement. The shares are to be purchased
at four closings (each, a “Closing”). The first closing is occurring simultaneously with the execution and delivery of this
Agreement (the “First Closing”). The second Closing shall occur on or before October 1, 2021, the third Closing shall occur
on or before January 3, 2022, and the fourth Closing shall occur on or before April 1, 2022. At each closing, subject to fulfillment of
the conditions to closing contained herein, the Company will sell and the Investor will purchase one-fourth of the aggregate number of
Preferred Shares (as defined below) indicated on the signature page as being purchased by the Investor.

 

2. Closing Actions and Deliveries.
At each Closing, the Investor will wire in immediately available funds to the Company the purchase price for the Preferred Shares being
purchased, and the Company will deliver to the Investor the Shares to be purchased at such closing (or evidence of ownership acceptable
to the Investor). The documents to be delivered at the First Closing (the “Transaction Documents”) are listed in the closing
agenda (the “Closing Agenda”) attached as Schedule 3, such documents having been reviewed and approved by the parties hereto.
The form of the amendment to the Company’s corporate charter to be in effect at the first Closing is attached as Schedule 4 (the
“Restated Certificate”). It is a condition to the obligations of the Investor to purchase Shares at the First Closing that
no material adverse change in the business or financial condition of the Company has occurred since January 1, 2021; and it is a condition
to the obligation of the Investor to purchase Preferred Shares at the subsequent closings that there has not been a material adverse change
in the business or financial condition of the Company since the immediately preceding closing, and separately, that the Company’s
representations and warranties being made at the First Closing, as modified by the Disclosure Schedule (which may be updated, as applicable,
prior to each Closing), shall be true and correct in all material respects at each such subsequent Closing. It is a condition to the obligations
of the Investor to purchase Shares at the First Closing that all outstanding convertible securities and other stock purchase rights (including
all SAFE rights) shall be converted into shares of Series A Preferred. The shares of Series A Preferred issued pursuant to this Agreement
to the Investor and to the SAFE Holders are collectively referred to as the “Preferred Shares.” The shares of capital stock
of the Company are collectively referred to as the “Shares”.

 

    

     

    

 

3. Conversion of Convertible
Securities. The Company previously issued convertible securities in the form of SAFEs (each, a “Convertible Security” and
collectively, the “Convertible Securities”) to the SAFE Holders. Notwithstanding any provision contained in the Convertible
Securities and subject to the terms and conditions set forth in this Agreement, each SAFE Holder hereby acknowledges and agrees that (i)
at the First Closing, all issued and outstanding Convertible Securities held by such SAFE Holder will convert into that number of Preferred
Shares and at the price per share as set forth opposite such SAFE Holder’s name on Schedule 1, (ii) other than such Preferred Shares
set forth opposite such SAFE Holder’s name on Schedule 1, such SAFE Holder hereby waives any rights under such Convertible Securities
to receive or purchase any other securities of the Company in connection with the conversion of such Convertible Securities, (iii) upon
such conversion at the consummation of the First Closing, the Company will be forever released from any and all of its obligations and
liabilities under the applicable Convertible Security, (iv) such Convertible Securities shall be, effective upon the First Closing, terminated,
cancelled and deemed satisfied in full without any further action by such SAFE Holder, (v) no fractional shares shall be issued upon conversion
of any Convertible Security and the right to receive cash in lieu of any fractional share shall be waived, and (vi) each SAFE Holder hereby
waives in connection with such conversion any notices required by the terms of such Convertible Securities. Such SAFE Holder hereby represents
and warrants that such SAFE Holder has good and marketable title to such Convertible Securities, and has not transferred, pledged or otherwise
disposed of any interest in the Convertible Securities (whether arising by contract, by operation of law or otherwise).

 

4. Capitalization Table. Attached
as Schedule 5 is an equity capitalization table for the Company (the “Cap Table”) as of immediately after the First Closing.
Set forth on the Cap Table is a complete list of all holders of shares of common stock (the “Common Stock”), Preferred Shares,
warrants, options, convertible notes and other equity securities of the Company outstanding immediately after the First Closing.

 

B. Representations of the Company. The Company
hereby represents and warrants that the following representations are complete and correct except as set forth in the disclosure schedule
(the “Disclosure Schedule”) attached hereto as Schedule 6, which references the sections of this Agreement to which the disclosure
it applicable.

 

1. Organization and Corporate
Power. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. The
Company has all required corporate power and authority to execute and perform this Agreement and the Transaction Documents.

 

2. Validity; Non-Contravention.

 

(a) Validity. The Company has
full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Company, will constitute valid
and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement
of creditors’ rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or
other equitable remedies.

 

(b) Non-Contravention. No consent,
approval or authorization of, or designation, declaration or filing with, any governmental authority or any other person or entity is
required of the Company in connection with the execution, delivery and performance of the Transaction Documents in accordance with the
terms thereof, a charter amendment having been filed prior to the First Closing. The Company is not in violation of, and the execution
and performance of the Transaction Documents will not conflict with or result in any default or event of default under, any agreement,
instrument, judgment, order, statute or government regulation applicable to the Company.

 

    2

     

    

 

3. Capitalization. All of
the outstanding equity securities of the Company as of immediately after the First Closing are correctly set forth on the Cap Table, and
except as set forth in this Agreement, there is no other right of any nature, direct or indirect, contingent or otherwise to acquire securities
of the Company, including without limitation any promise of equity to actual or prospective employees or service providers to the Company.
The Company has no obligation (contingent or otherwise) to purchase, redeem or otherwise acquire any shares of its capital stock or any
interest therein or to pay any dividend or make any other distribution in respect thereof, except (i) as set forth in the Restated Certificate
and (ii) for the purchase of unvested Common Stock at cost from terminated employees. Except as set forth in this Agreement, no person
or entity is entitled to: (i) any preemptive, right of first refusal or similar right with respect to the issuance of any equity securities
of the Company, or (ii) any rights with respect to the registration of any capital stock of the Company under the Securities Act of 1933,
as amended (the “Securities Act”).

 

4. Newly Organized Corporation.
The Company is recently organized, has no material liabilities and is not a party to any material agreements, except as set forth in the
Disclosure Schedule, and has not entered into, or committed to enter into, any material agreements or arrangements (except for the Transaction
Documents). Total gross investment proceeds received by the Company since its organization cumulatively total $75,000.

 

5. Material Contracts. All
of the Company’s agreements and other contractual arrangements in effect as of the date of this agreement involving more than $25,000
or are otherwise material are as set forth in the Disclosure Schedule (the “Material Contracts”). To the Company’s
knowledge, no party is in default under any of the Material Contracts.

 

6. Intellectual Property.

 

(a) Generally. To the Company’s
knowledge, the Company owns or is licensed to use all material patents, copyrights, trade secrets and other intellectual property rights
necessary for the business of the Company as presently conducted or as proposed in writing to be conducted. There are no actual or written
proposals for licenses with respect to the Company’s intellectual property. The Company is not bound by or a party to any options
or agreements with respect to any licenses to the Company’s intellectual property. The Company has not received any written communication
alleging that the Company has violated any of the intellectual property of any other person or entity, and the Company knows of no threats
with respect thereto.

 

(b) Confidentiality and Invention
Assignment. Each technical and managerial employee of the Company has executed a customary confidentiality, assignment of inventions agreement
for the benefit of the Company, a copy of each of which has been furnished to counsel for the Investor. To the Company’s knowledge,
no party thereto is in violation of any such agreement.

 

(c) No Violation of Other Agreements.
To the Company’s knowledge, no current or former employee or consultant of the Company has used or expects to use any intellectual
property, including trade secrets or other confidential information, of any other person in the course of their work for the Company,
and the activities of the Company’s employees and consultants on behalf of the Company do not violate and are not expected to violate
any agreements or arrangements known to the Company which any such employees or consultants have with former employers or any other person
to whom such employees or consultants may have rendered services.

 

7. Litigation. There is no
litigation or governmental proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company,
or with respect to the Transaction Documents, or against any officer or key employee of the Company that relates to the Company’s
proposed business. To the Company’s knowledge, there has not occurred any event nor does there exist any condition on the basis
of which any litigation, proceeding or investigation might properly be instituted.

 

    3

     

    

 

8. Securities Act Registration.
Assuming that the representations and warranties of the Investor contained herein are true, and subject to filings pursuant to applicable
securities laws, which will be made in a timely manner, it is not necessary in connection with the offer, sale and delivery of the Shares
in the manner contemplated by this agreement to register the Shares under the Securities Act or under applicable state laws regulating
the issuance or sale of securities.

 

9. Information Supplied to
Investors. No document furnished to the Investors by the Company intentionally contains any untrue statement of a material fact or intentionally
omits to state a material fact necessary in order to make the statements contained herein or therein not misleading.

 

C. Representations of Each Key Person. Mark Crawford
and Eddy Chiang (each, a “Key Person”), severally and not jointly, represents to the Investor that, to his actual knowledge,
that (i) the representations and warranties of the Company contained in Sections 2.3, 2.6 and 2.7 (as modified by the Disclosure Schedule)
are correct and complete in all material respects and (ii) he is not in violation of any term of any employment contract, patent disclosure
agreement, proprietary information agreement, noncompetition agreement, nonsolicitation agreement or any other contract or agreement or
any restrictive covenant to which he individually is a party relating to his right to be employed full-time by the Company or relating
to the Company’s use of trade secrets, proprietary information or intellectual property rights of others.

 

D. Representations and Covenants of the Investor.
Each Investor and SAFE Holder (a “Purchaser”) hereby represents and warrants to the Company, severally and not jointly, that:

 

1. Securities Laws Representations.
The Purchaser represents and warrants to the Company that it: (i) is an “accredited investor” as such term is defined in Regulation
D under the Securities Act of; (ii) is acquiring the Shares for its own account for investment and not with a view to, or for sale in
connection with, any distribution thereof in contravention of the Securities Act; (iii) understands that this investment is speculative
and involves a high degree of risk of loss of the entire investment, and there are substantial restrictions on the transferability of,
and there will be no public market for, the Shares; (iv) is able to bear the economic risk of this investment and to hold the Shares for
an indefinite period of time; has made other so-called “angel investments” in other private technology-based companies; and
(v) its representatives have been given the opportunity to ask questions of, and to receive answers from, management and other persons
acting on behalf of the Company concerning the Company and the terms and conditions of transaction contemplated by this Agreement, and
to obtain any additional information requested.

 

2. Restricted Securities.
The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific
exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment
intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands that the Shares are “restricted
securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the
Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption
from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register
or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in Section 4 of this Agreement.
The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various
requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating
to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation and may not be able to
satisfy. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not
be able to rely on the protection of Section 11 of the Securities Act.

 

3. No Public Market. The Purchaser
understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever
exist for the Shares.

 

    4

     

    

 

4. Residence. If the Purchaser
is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on the signature
page; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser
in which it has its principal place of business is identified in the address or addresses of the Purchaser set forth on the signature
page.

 

E. Covenants of the Company.

 

1. Pre-Emptive Rights.

 

(a) Grant of Right. The Company
hereby grants to the Investor the right to purchase its Pro Rata Share of New Securities which the Company may, from time to time, propose
to sell and issue after the date of this agreement. “Pro Rata Share” means a percentage equal to (x) the number of shares
held by the Investor and its affiliates (on an as converted to Common Stock basis) divided by (y) all outstanding shares of common stock
of the Company (including all convertible securities on an as-converted basis, it being understood that shares reserved for issuance are
not included). “New Securities” means any equity securities (including Common Stock and/or preferred stock) of the Company
whether now authorized or not, and rights, convertible securities, options or warrants to purchase such equity securities being issued
by the Company for the purpose of financing its business; provided that the term “New Securities” does not include; (i) securities
issued in exchange for services rendered to the Company; (ii) securities subject to vesting provisions issued as incentives to employees,
consultants, directors and advisors to the Company to remain in service to the Company; (iii) securities issuable upon conversion or exercise
of other securities; (iv) securities issued to a bank in connection with a loan facility, and (v) securities issued with the unanimous
approval of the Board of Directors and which resolutions state such securities shall not be deemed “New Securities”.

 

(b) Procedures. In the event
the Company proposes to undertake an issuance of New Securities, it shall give the Investor written notice of its intention to do so,
describing the type of New Securities, and their price and terms in reasonable detail. Such notice shall be given in accordance with procedures
established by the Board of Directors in each such instance. If determined to be necessary by the Board of Directors, New Securities may
be offered promptly to the Investor in the amount required after the completion of the initial issuance of the New Securities.

 

2. Additional Covenants of
the Company. Except to the extent the following covenants and provisions of this Section 5.2 are waived in any instance by the Board of
Directors, which approval must include the affirmative vote or consent of a majority of the Directors, including a Series A Director (as
defined below), the Company agrees as follows:

 

(a) Basic Information. The Company
will furnish the following reports to the Investor as soon as practicable after the end of each fiscal quarter of the Company: (i) an
unaudited summary balance sheet and summary statement of cash flows of the Company for the quarterly period then ended, such financial
statements to be prepared in summary form in good faith and need not conform to generally accepted accounting principles; (ii) an updated
equity capitalization table; and (iii) a general business update. In addition, prior to the commencement of each quarter, the Company
will provide the Investor with its proposed budget for the succeeding quarter.

 

(b) Information Rights. The
Company hereby grants the Investor a right of access to the Company’s facilities and personnel during normal business hours and
with reasonable advance notice, and agrees that the Investor will be furnished any information about the Company that is requested by
it that is relevant to its ownership of the Company’s securities, provided that the Investor shall have executed a confidentiality
agreement furnished by the Company prior to the receipt of any confidential information. The foregoing shall not require the Company to
furnish any information that is a trade secret or classified (other than a general description thereof), and shall not require the Company
to furnish any information to a person believed to be associated with a competitor of the Company.

 

    5

     

    

 

(c) IP and Agreements with Affiliates.
The Company will enter into a confidential information and invention assignment agreement with each new technical and managerial employee
or consultant, as well as a non-competition agreement (if and where enforceable by applicable law) prohibiting competition with the Company
for a period ending one year after termination of employment with the Company for any reason. The Company will not enter into any agreements
with its related persons and affiliates (as defined in Nasdaq regulations) without the prior unanimous approval of the Board of Directors.

 

(d) Board of Directors. The
Company, the Investor, each SAFE Holder and each Shareholder at all times vote all shares then-held by such party and take any other necessary
actions to cause its Board of Directors to consist of five seats, and to elect and keep in office the following persons:

 

(i) the Company’s chief
executive officer, initially, Mark Crawford;

 

(ii) the Company’s chief
operating officer, initially Eddy Chiang;

 

(iii) two representatives
of the Investor (the “Series A Directors”), initially David Solomont and Thomas Shane, and;

 

(iv) an independent director
with industry and/or startup experience who is acceptable to the other directors, initially Corey Clothier.

 

Notwithstanding the foregoing, if the Investor
has not purchased an aggregate of $1.5 million of Preferred Shares (including all Shares purchased at the First Closing and any closings
thereafter) on or prior to January 10, 2022, then (i) the Investor shall cause 1 of the Series A Directors to immediately resign or be
removed from the Board of Directors, (ii) the size of the Board of Directors shall be reduced to four seats, and (iii) the Investor shall
thereafter be entitled to elect and keep in office just one (1) Series A Director. Each party agrees to vote all shares then-held by such
party and take any other necessary actions to effect the foregoing.

 

The Company will reimburse the non-employee directors
for all reasonable expenses they incur in fulfilling Board duties. Any Board committees will have at least one Series A Director as one
of its members. In addition, the Company will obtain and have in effect directors and officers insurance in form and amount acceptable
to the Investor.

 

(e) Special Board Meetings.
The Company will convene one or more special meetings of the Board of Directors at any time reasonably requested by the Investor, but
not more than once each calendar quarter.

 

(f) Dealings with Affiliates.
The Company will not enter into any transaction, including, without limitation, any loans, leases, extension of credit or royalty agreements
with any employee, officer or director of the Company, or any member of their respective immediate families or any corporation or other
entity directly or indirectly controlled by one or more of such persons.

 

(g) Registration Rights. In
the event that the Company grants to any future investors “registration rights” relating to the registration of shares under
the Securities Act of 1933, it will grant equivalent rights to the Investor, either pursuant to the agreement executed for the benefit
of such new investors or a separate agreement. In addition, in the event the Company begins preparation for an initial public offering
and no such registration rights agreement has been entered into, the Company will enter into a customary registration rights agreement
with the Investor granting piggy-back and shelf registration rights.

 

    6

     

    

 

(h) Commercial Relationship.
Prior to the first sale of any product by the Company, the parties will negotiate in good faith a “most favored nation” supply
agreement with the Investor governing the supply of the Company’s products, including (i) vehicle routing optimization for Investor’s
vehicles; (ii) an autonomous driving system for on-road operation of Investor’s vehicles; and (iii) integration of delivery robots
and handling system into the Investor’s vehicles.

 

(i) Equity Grants. All grants
of options and other securities to employees and other persons intended to be retention incentives will provide that the first vesting
date of each grant will be on the first anniversary of the grant. Vesting for this purpose means termination of forfeiture provisions
upon termination of service. Any additional issuances of equity securities to a Shareholder must be unanimously approved by the Board
of Directors.

 

(j) Termination of Covenants.
The rights established by Sections 5.1 and 5.2 shall terminate upon the earliest of: (i) immediately prior to the closing of an firm
commitment underwritten initial public offering by the Company of its Common Stock with a concurrent registration on a national securities
exchange; or (ii) a sale of the Company triggering the Investor’s liquidation preference in the Company’s corporate charter
or (iii) as permitted by the unanimous vote or written consent of the Company’s Board of Directors.

 

F. Transfers of Shares.

 

1. Restrictions on Transfer.
Each Stockholder agrees not to sell, assign, transfer, pledge or otherwise dispose of any shares of Common Stock without the consent of
the Board of Directors of the Company, except for a transfer not involving a change in beneficial ownership. The provisions of this Section
6.1 shall terminate at the same time that the Company’s covenants in Section 5 terminate. Each certificate or other evidence of
ownership of such shares of Common Stock shall indicate that the Shares represented thereby are subject to regarding these restrictions
and securities laws restrictions.

 

2. Right of First Refusal
and Co-Sale.

 

(a) Sales to Third Parties.
If at any time during the term of this Agreement a Key Person (each, a “Selling Stockholder”) desires to sell for cash all
or any part of the shares of capital stock of the Company beneficially owned by him (the “Subject Shares”), such Selling Stockholder
shall first notify the Company of all material terms of such proposed sale and the identity of the proposed transferee. The Company shall
have the first right, and the Investor the second right, to purchase on the specified terms all but not less than all of the Subject Shares
in accordance with procedures promptly to be specified by the Company with notice to the Selling Stockholder and the Investor. If the
Company does not wish to purchase all of the Subject Shares, the Investor shall have the right to do so in accordance with the procedures
specified by the Company. If all of the Subject Shares are not so purchased, the Selling Stockholder may sell to the originally named
proposed transferee the Subject Shares, but only at the same or greater price and upon other terms and conditions, if any, not more favorable
to the transferee than those originally specified by the Selling Stockholder. The Company shall specify a time period not less than 30
days during which such sale may take place. The third party purchaser shall not be subject to the same sale restrictions as the Selling
Stockholder.

 

(b) Investor’s Co-Sale
Right. If a Selling Stockholder proposes to transfer Subject Shares pursuant to subparagraph (a), the Investor shall have the right to
sell to the originally specified proposed transferee, at the same price per share and on the same terms and conditions as involved in
such sale by the Selling Stockholder its Pro Rata Share of the total number of shares being sold.

 

    7

     

    

 

(c) Certain Exceptions. The
restrictions set forth in Sections 6.1 and 6.2 shall not apply to any of the following transfers (i) any transfers of Subject Shares by
a Selling Stockholder to Selling Stockholder’s spouse, ex-spouse, domestic partner, lineal descendant or antecedent, brother or
sister, the adopted child or adopted grandchild, or the spouse or domestic partner of any child, adopted child, grandchild or adopted
grandchild of Selling Stockholder, or to a trust or trusts for the exclusive benefit of Selling Stockholder or those members of Selling
Stockholder’s family specified in this clause (i), or transfers of Subject Shares by Selling Stockholder by devise or descent; (ii)
with respect to each Selling Stockholder, up to an aggregate of five percent (5%) of the Subject Shares held by such Selling Stockholder
as of the date of this Agreement; or (iii) any repurchase of Subject Shares by the Company.

 

(d) Termination of Covenants
and Restrictions. The rights and restrictions established by Sections 4 and 5 and shall terminate at such time as the Investor no longer
beneficially owns at least 50% of the Shares purchased by the Investor pursuant to this Agreement (the “Requisite Shares”).

 

G. Miscellaneous.

 

1. Amendment. Except as expressly
provided herein, neither this agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument
referencing this agreement and signed by (i) the Company, (ii) the Investor, and (iii) SAFE Holders and the Shareholders holding a majority
of the Shares then-held by such persons; provided that investors purchasing Shares in a closing after the last scheduled Closing may become
parties to this Agreement by an instrument signed by the Company in a form approved by the Investor and the Board of Directors.

 

2. Notices. All notices and
other communications required or permitted hereunder shall be in writing and shall be transmitted by email or otherwise delivered by hand
or by messenger addressed:

 

	 	●	if to the Investor, a SAFE Holder or the Shareholders, at such party’s email address as shown in the Company’s records, as may be updated by such party by notice to the Company; and
	 	 	 

 

	 	●	if to the Company, to the Company’s chief executive officer at his or her email address as shown in the Company’s records.

 

With respect to any notice given by the
Company under any provision of the Delaware General Corporation Law or the Company’s charter or bylaws, the Investor agrees that
such notice may be given by email as provided above.

 

3. Governing Law. This Agreement
shall be governed in all respects by the internal laws of the State of Delaware.

 

4. Expenses. The Company shall
pay all legal and administrative costs of this transaction at the first Closing and each subsequent Closing, including the reasonable
fees and expenses of counsel to the Investor, up to an aggregate maximum of $10,000.

 

5. Successors and Assigns.
Except as otherwise provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors,
assigns, heirs, executors and administrators of the parties hereto.

 

6. Execution and Electronic
Delivery. An executed copy of this agreement may be delivered by fax or email attachment. An original signed copy shall not be necessary
for any purpose.

 

7. Brokers. The Company and
the Investors each represent and warrant to the other that it has retained no finder or broker in connection with the transactions contemplated
by this Agreement.

 

    8

     

    

 

8. Dispute Resolution. The
parties (a) hereby irrevocably and unconditionally submit to the exclusive jurisdiction of the state and federal courts of Delaware for
the purpose of any suit, action or other proceeding arising out of or based upon this Agreement.

 

9. Market Stand-Off Agreement.
If requested by the underwriters of the Company, each party shall not sell or otherwise transfer, make any short sale of, grant any option
for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, of any Common Stock (or
other securities) of the Company held by such party immediately prior to the effective date of the registration statement for such offering
(other than those included in the registration) during the period from the filing of the registration statement for the Company’s
Initial Public Offering filed under the Securities Act that includes securities to be sold on behalf of the Company to the public in an
underwritten public offering under the Securities Act through the end of the 180-day period following the effective date of the registration
statement (or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (i) the
publication or other distribution of research reports and (ii) analyst recommendations and opinions, including, but not limited to, the
restrictions contained in NYSE Rule 472(f)(4), or any successor provisions or amendments thereto), provided that (A) all officers and
directors of the Company and holders of at least one percent (1%) of the Company’s voting securities are bound by and have entered
into similar agreements and (B) any discretionary waiver or termination of the restrictions of such agreements by the Company or representatives
of the underwriters shall apply to the holders of registrable securities, pro rata, based on the number of shares held. The obligations
described in this Section 7.9) shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or
similar forms that may be promulgated in the future, or a registration relating solely to a transaction on Form S-4 or similar forms that
may be promulgated in the future. The Company may impose stop-transfer instructions and may notate each such certificate, instrument or
book entry with an appropriate legend with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction
until the end of such one hundred eighty (180) day (or other) period. Each party agrees to execute a market standoff agreement with said
underwriters in customary form consistent with the provisions of this Section 7.9.

 

(Signature page(s) immediately follow.)

  

    9

     

    

 

Signature Page to Interplai, Inc.

Stock Purchase Agreement

 

The Company, the Investor,
the SAFE Holders and the Shareholder hereby execute this Stock Purchase Agreement as of the date set forth immediately below.

 

Dated: August 30, 2021

 

INVESTOR:

 

	$1,999,999.86 ($499,999.73 at each of the First, Second and Third Closings; $500,000.67 at the Fourth Closing)	 	Ev Transportation Services, Inc.
	
    Aggregate dollar amount being purchased↑

     

    $0.4693
	 	Investor’s name↑
	Per Share purchase price↑	 	 
	 	 	 
	 	 	Investor’s signature↑
	 4,261,666 (1,065,416 at each of the First, Second and Third Closings; 1,065,418 at the Fourth Closing)	 	 
	Aggregate number of Shares being purchased↑	 	Name and Title of signatory, if Investor is an entity↑
	 	 	 
	
     

    INTERPLAI, INC.
	 	Address of Investor↓
	 	 	 
	By: 	             	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	Email address:
	 	 	 

 

    

     

    

 

Signature Page to Interplai, Inc.

Stock Purchase Agreement

 

The Company, the Investor, the SAFE Holders and
the Shareholder hereby execute this Stock Purchase Agreement as of the date set forth immediately below.

 

Dated: August 30, 2021

 

SAFE HOLDERS:

  

Mark Crawford

  

Jonathan David

 

STOCKHOLDERS:

  

Mark Crawford

  

Eddy ChiangExhibit 10.7

 

www.evtaas.com

 

Offer of Employment, dated as of March 31,
2021, by and between the Registrant and David Solomont

 

March 31, 2021

 

Dear David,

 

On behalf of the Board of Directors
(the “Board”) of ev Transportation Services, Inc. (hereafter “evTS” or the “Company”), we are pleased
to offer you the position of President, on the terms and conditions set forth in this Employment Letter Agreement (this “Agreement”)

 

Employment by the Company:
Your official title will be President. This is a full time, exempt position, and during your employment with the Company, you will devote
your best efforts and substantially at; of your business time and attention to the business of the Company. You shall perform such duties
as are normally associated with this position and such duties as are assigned to you by the Board of Directors.

 

Starting Date: April 1, 2021

 

Salary: For services to be rendered
hereunder, you shall receive a base salary at the rate of $360,000 per year, subject to standard deductions and withholdings and payable
in accordance with the Company’s customary payroll procedures as established and modified from time to time (hereinafter referred
to as your Base Compensation”).

 

Stock: Subject to the approval of the
Board, you will be granted a stock grant for that number of shares of Company common stock determined by the Governance Committee of the
Board of Directors. This stock grant will be subject to repurchase, in accordance with the Company’s standard vesting schedule.
You should consult with your own tax advisor the tax risks and consequences related to this stock grant.

 

Contingencies: This offer is contingent
upon (i) your executing the Company’s Restrictive Covenant Agreement (the “Restrictive Covenant Agreement”), (ii) your
satisfying the eligibility requirements for employment in the United States and (iii) satisfactory background and reference checks (in
the Company’s sole discretion).

 

Personnel Policies and Benefits: The
employment relationship between yourself and the Company shall be governed by the genera! employment policies and practices of the Company,
as they may be interpreted, adopted, revised or deleted from time to time in the Company’s sole discretion. You shaft be entitled
to participate in al! employee benefit programs for which you are eligible under the terms and conditions of the benefit plans that may
be in effect from time to time and provided by the Company to similarly situated employees. The Company expects to provide individual
and family health and dental insurance as well as vacation and sick leave. You will be eligible for three weeks of paid vacation* The
Company may modify, revoke, suspend or terminate any of the terms, pians, policies and/or procedures described in the employee handbook,
if any, or as otherwise communicated to you, in whole or part, at any time, with or without notice.

 

Confidential Information and Restrictive
Covenants: As a condition of your continued employment, you agree to execute and abide by the terms of the Restrictive Covenant Agreement,
which shah survive termination of your employment with the Company and the termination of this Agreement.

 

 

 

    1

     

    

 

	 	 	 

 

Not in Violation of Any Obligation to
Others: By acceptance of this offer of employment, you represent and agree that your employment with evTS shall not violate any agreements,
obligations or understandings that you may have with any third party or prior employer. Without limiting the foregoing, you represent
and agree that you are not bound by any non-compete or non-solicitation agreement or any other type of agreement that would prohibit your
employment with the Company, If you are a party to any such agreement, you are also certify that you have provided us with copies of any
such agreements that you are a party to in conjunction with any current and/or former employment.

 

Employment at Will: Please note that
this Agreement and your response are not meant to constitute a fixed-term employment contract and that you witl remain, at ail times,
an employee at-wiil, which means that either you or the Company wili be entitled terminate your employment at any time and for any reason,
with or without cause, Any contrary representations that may have been made to you are superseded by this Agreement. This is the fuli
and complete agreement between you and the Company on this term.

 

Miscellaneous: This Agreement shall be governed,
construed and enforced in accordance with the laws of Massachusetts without regard to principles of conflicts of law. tn the event of
any litigation relating to this Agreement, the parties agree that the exclusive venue and jurisdiction shall be the circuit courts of
Middlesex County, Massachusetts. Should any provision of this Agreement or any portion thereof* be found invalid and unenforceable, it
shall be construed to be enforceable to the greatest extent allowable under applicable law, and the remaining provisions shall continue
in force and effect. By signing this Agreement, you acknowledge that the terms described in this Agreement, together with the Restrictive
Covenant Agreement, sets forth the entire understanding between yourself and the Company and supersedes any prior representations or agreements,
whether written or oral; there are no terms, conditions, representations, warranties or covenants other than those contained herein. No
term or provision of this Agreement may be amended, waive, released, discharged or modified except in writing, signed by you and the appropriate
designee of the Board, except that the Board may at any time, in its sole discretion, adjust your Base Compensation, incentive compensation,
stock plans, benefits, job titles, locations, duties and responsibilities subject to your option to elect to terminate your employment.
This Agreement is intended to bind and inure to the benefit of and be enforceable by you and the Company, and their respective successors,
assigns, heirs, executors and administrators, except that you may not assign any of your duties hereunder and you may not assign any of
your rights hereunder, without the written consent of the Company. This Agreement may be signed in counterpart, with signature pages copied
and/or faxed to the other party. Upon signing by all Parties, this Agreement shall constitute one complete agreement.

 

David, we are excited to have you join
us and enthused at the prospect of tackling a very promising future together. We look forward to a long and mutually rewarding relationship.

 

[Signature Page Follows]

 

    2

     

    

 

	 	 	 

 

[Signature Page to evTS Employment Letter Agreement]

 

Agreed to, accepted and acknowledged:

 

A. Paw:”

David Solomont

 

    3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]